DE69222065D1 - Dapsone und promin zur behandlung der demenz - Google Patents

Dapsone und promin zur behandlung der demenz

Info

Publication number
DE69222065D1
DE69222065D1 DE69222065T DE69222065T DE69222065D1 DE 69222065 D1 DE69222065 D1 DE 69222065D1 DE 69222065 T DE69222065 T DE 69222065T DE 69222065 T DE69222065 T DE 69222065T DE 69222065 D1 DE69222065 D1 DE 69222065D1
Authority
DE
Germany
Prior art keywords
promin
dapsone
dementia
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69222065T
Other languages
English (en)
Other versions
DE69222065T2 (de
Inventor
Patrick Mcgeer
Nobuo Harada
Hiroshi Kimura
Edith Mcgeer
Michael Schulzer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of British Columbia
Original Assignee
University of British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of British Columbia filed Critical University of British Columbia
Application granted granted Critical
Publication of DE69222065D1 publication Critical patent/DE69222065D1/de
Publication of DE69222065T2 publication Critical patent/DE69222065T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69222065T 1992-05-29 1992-05-29 Dapsone und promin zur behandlung der demenz Expired - Fee Related DE69222065T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CA1992/000228 WO1993024118A1 (en) 1992-05-29 1992-05-29 Dapsone and promin for the treatment of dementia

Publications (2)

Publication Number Publication Date
DE69222065D1 true DE69222065D1 (de) 1997-10-09
DE69222065T2 DE69222065T2 (de) 1998-04-09

Family

ID=4172933

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69222065T Expired - Fee Related DE69222065T2 (de) 1992-05-29 1992-05-29 Dapsone und promin zur behandlung der demenz

Country Status (4)

Country Link
EP (1) EP0642337B1 (de)
JP (1) JP3295423B2 (de)
DE (1) DE69222065T2 (de)
WO (1) WO1993024118A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040208875A1 (en) 1995-03-15 2004-10-21 Queen's University At Kingston Method for treating amyloidosis
US5840294A (en) * 1993-03-29 1998-11-24 Queen's University At Kingston Method for treating amyloidosis
AU2001239052A1 (en) * 2000-03-06 2001-09-17 Immune Network Ltd. Compositions for prevention and treatment of dementia
US20060211748A1 (en) * 2002-07-11 2006-09-21 Bain Allen I Sulphydryl compounds in combination with sulpha compounds
US8044100B2 (en) 2004-12-22 2011-10-25 Bellus Health Inc. Methods and compositions for treating amyloid-related diseases
CA2634871A1 (en) 2005-12-22 2007-11-08 Neurochem (International) Limited Treatment of renal disorders, diabetic nephopathy and dyslipidemias
FI3851447T3 (fi) 2006-10-12 2023-11-15 Bellus Health Inc Menetelmiä, yhdisteitä, koostumuksia ja vehikkeleitä 3-amino-1-propaanisulfonihapon vapauttamiseksi
WO2013019926A1 (en) * 2011-08-04 2013-02-07 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Treatment and prevention of diseases mediated by microorganisms via drug-mediated manipulation of the eicosanoid balance
WO2020159044A1 (ko) * 2019-02-01 2020-08-06 이종훈 뎁손을 유효성분으로 함유하는 인지기능 장애의 예방 또는 치료용 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3923088A1 (de) * 1989-07-13 1991-01-24 Saarstickstoff Fatol Gmbh Kombinationspraeparate zur behandlung rheumatoider erkrankungen

Also Published As

Publication number Publication date
DE69222065T2 (de) 1998-04-09
JP3295423B2 (ja) 2002-06-24
EP0642337A1 (de) 1995-03-15
EP0642337B1 (de) 1997-09-03
JPH07506804A (ja) 1995-07-27
WO1993024118A1 (en) 1993-12-09

Similar Documents

Publication Publication Date Title
ATE201138T1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung und prophylaxe der multiplen sclerose
DE69222258T2 (de) Einrichtung und Verfahren für die Behandlung von Aussenwänden
DE69224080T2 (de) Verwendung von nsaid zur behandlung von demenz
DE69331265T2 (de) Verbindungen zur behandlung von entzündlichen erkrankungen und zur hemmung der produktion von tumornekrosefaktor
DE69312624T2 (de) Vorrichtung zur unterscheidung von tachykardien und fibrillationen und zur entsprechenden behandlung
NO174492C (no) Fremgangsmåte og installasjon for behandling av væske
DE69739758D1 (de) Vakzine zur behandlung von lymphomen und leukämie
DE69318693T2 (de) Magnetischer Konditionierer zur Behandlung von Flüssigkeiten
DE69115921D1 (de) Verfahren zur behandlung und verwendung von abfallstoffen
DE69422842T2 (de) Verfahren und Einrichtung zur Behandlung von Lithium
DE69532066D1 (de) Arzneimittel zur Behandlung von Restenosis und Gefässsklerose
NO914665L (no) Fremgangsmaate til fjerning av trialkylarsiner og sorpsjonsmateriale for utfoerelse av fremgangsmaaten
DE69426848D1 (de) Gerät zur Behandlung von lichtempfindlichen Materialien
DE68929516D1 (de) Verfahren zur Konservierung ophthalmischer Lösungen und Zusammensetzungen dafür
DE69222065D1 (de) Dapsone und promin zur behandlung der demenz
DE69325675T2 (de) Verfahren zur Herstellung von Amid-Verbindungen und Mikroorganismus dafür
NO171798C (no) Fremgangsmaate for behandling av sinkholdige biprodukter og avfallsmaterialer
DE59308018D1 (de) Verfahren und Mittel zur oxidativen Zerstörung von Aziden
DE69412178T2 (de) Apparat zur Behandlung von Lagen
DE3586420D1 (de) Verwendung von dihydropyridinen zur behandlung und praevention von arteriosklerose.
NO920983D0 (no) Fremgangsmaate for behandling av nevrodegenerative tilstander
DE69420078T2 (de) Gerät zur Behandlung photoempfindlichen Materials
DE69715878D1 (de) Formulierung zur behandlung und/oder vorbeugung von dementia
DE4395515T1 (de) Verfahren zur Isolierung und Reinigung von Mevinolin
DE59206187D1 (de) Verfahren zur Herstellung von 4-Alkylsulfonyl-1-alkyl-2-chlorbenzolen und Zwischenprodukte

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee